Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts INTS Hot Sheet
Join SI Premium – FREE
Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q2 EPS of ($1.11), $0.24 worse than the analyst estimate of ($0.87).
For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts falls on revenue miss, weak guidance
- Cerebras and Callosum partner on agentic AI inference platform
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
